Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03934164 | Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO(MAESTRO) | unknown | — | 600 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT04484038 | Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma | unknown | N/A | 300 | Grupo de Investigación Clínica en Oncología RadioterapiaOTHER |
| 1 |
| Jul 23, 2020 |
| clinicaltrials |
| NCT03506997 | Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer(PERSEUS1) | unknown | Phase 2 | 100 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT03857113 | Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study(TRACE) | unknown | — | 20 | The Netherlands Cancer InstituteOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04011865 | Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer Treatment | unknown | N/A | 80 | Binh Dan HospitalOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT02742675 | Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | unknown | Phase 2 | 200 | Fudan UniversityOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT03380806 | Prostate Boost Irradiation With Stereotactic Body RT (SBRT)(PBS) | unknown | Phase 2 | 100 | Juravinski Cancer CenterOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT01764646 | Hypofractionated Radiation Therapy in Prostate Cancer | unknown | N/A | 170 | Thomas ZilliOTHER | 8 | May 19, 2020 | clinicaltrials |
| NCT02691975 | A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients | unknown | Phase 1 / Phase 2 | 197 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | May 13, 2020 | clinicaltrials |
| NCT04369508 | PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy | unknown | — | 20 | Xuanwu Hospital, BeijingOTHER | 0 | Apr 30, 2020 | clinicaltrials |
| NCT00326638 | 3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer | unknown | N/A | 72 | Ottawa Hospital Research InstituteOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT04102904 | The Prostate Liquid Study (PLiS)(PLiS) | unknown | — | 300 | University College, LondonOTHER | 1 | Mar 26, 2020 | clinicaltrials |
| NCT04322045 | Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening | unknown | N/A | 10,000 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Mar 26, 2020 | clinicaltrials |
| NCT04320147 | MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer | unknown | N/A | 300 | Asan Medical CenterOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT03787823 | RCT-evaluation of Retzius-sparing Robotic Prostatectomy | unknown | N/A | 186 | Heidelberg UniversityOTHER | 1 | Mar 24, 2020 | clinicaltrials |
| NCT04317625 | Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL | unknown | N/A | 232 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT04297410 | 177Lu-PSMA-I&T Prior to Radical Prostatectomy for Locally Advanced Disease(NALuPROST) | unknown | N/A | 5 | Rabin Medical CenterOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT04292041 | Fasting Mimicking Diet in Prostate Cancer and Metabolic Syndrome | unknown | — | 40 | Galway ClinicNETWORK | 1 | Mar 2, 2020 | clinicaltrials |
| NCT04284020 | Educational Program Plus Physiotherapy After Prostatectomy | unknown | N/A | 84 | University of AlcalaOTHER | 1 | Feb 25, 2020 | clinicaltrials |
| NCT04278443 | Fertility After Prostate Brachytherapy | unknown | — | 40 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Feb 20, 2020 | clinicaltrials |
| NCT04206280 | Use of Pedometer Following Radical Prostatectomy | unknown | N/A | 40 | Benaroya Research InstituteOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT03522155 | Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies | unknown | N/A | 136 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 6, 2020 | clinicaltrials |
| NCT03225235 | Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate Cancer(CYBERPROST) | unknown | N/A | 600 | The Greater Poland Cancer CentreOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT02928692 | Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium(MAPOCD) | unknown | Phase 3 | 750 | RenJi HospitalOTHER | 1 | Jan 28, 2020 | clinicaltrials |
| NCT02362620 | PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.(PROSTAC) | unknown | — | 402 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT02787837 | PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.(PROSABI) | unknown | — | 220 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT02922218 | PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.(PROSENZA) | unknown | — | 187 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT02925702 | PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.(PRORADIUM) | unknown | — | 161 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT00561444 | Quality of Life Study for Prostate Cancer Patients | unknown | — | 1,051 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT04062162 | Walking Football as a Supportive Medicine for Patients With Prostate Cancer | unknown | N/A | 50 | Associacao de Investigacao de Cuidados de Suporte em OncologiaOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT04225910 | Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer | unknown | Early Phase 1 | 20 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Jan 13, 2020 | clinicaltrials |
| NCT02963155 | Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration(NKPROSTATE) | unknown | N/A | 30 | Institut Paoli-CalmettesOTHER | 1 | Jan 10, 2020 | clinicaltrials |
| NCT00489814 | Study of Quality of Life for Prostate Proton Therapy | unknown | — | 1,125 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT04220398 | Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer | unknown | N/A | 475 | RenJi HospitalOTHER | 0 | Jan 7, 2020 | clinicaltrials |
| NCT04066335 | Study to Evaluate the Safety of Nanoxel M Inj. | unknown | — | 1,498 | Samyang Biopharmaceuticals CorporationINDUSTRY | 1 | Dec 18, 2019 | clinicaltrials |
| NCT03838432 | The Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Ablation Therapy | unknown | N/A | 119 | Second Military Medical UniversityOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT04045756 | Focal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate Cancer | unknown | N/A | 50 | University of Rome Tor VergataOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT04191980 | Deep Learning for Prostate Segmentation(GOPI-Segm) | unknown | — | 62 | Hospices Civils de LyonOTHER | 1 | Dec 10, 2019 | clinicaltrials |
| NCT04188587 | 177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer | unknown | Phase 2 | 30 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Dec 6, 2019 | clinicaltrials |
| NCT04180592 | Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate. | unknown | N/A | 20 | Queen's UniversityOTHER | 1 | Dec 4, 2019 | clinicaltrials |
| NCT04182594 | Cardiovascular Events in GnRH Agonist vs. Antagonist | unknown | Phase 2 | 80 | Rabin Medical CenterOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT03786848 | Personalized Mini-PDX for Metastatic CRPC | unknown | N/A | 15 | Tianjin Medical University Second HospitalOTHER | 1 | Nov 26, 2019 | clinicaltrials |
| NCT03021200 | Laser Fluorescence in Cancer Surgical Treatment | unknown | N/A | 270 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Nov 12, 2019 | clinicaltrials |
| NCT04159051 | Charité HT-Prostate | unknown | N/A | 100 | Charite University, Berlin, GermanyOTHER | 1 | Nov 12, 2019 | clinicaltrials |
| NCT04159090 | Head- to Head Comparison of [68Ga]Ga-PSMA-11 With [18F]PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-Standard | unknown | N/A | 20 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Nov 12, 2019 | clinicaltrials |
| NCT04158414 | Applying PET/MR in Oncology - a Prospective Project | unknown | N/A | 500 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 8, 2019 | clinicaltrials |
| NCT04154280 | Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate Cancer | unknown | N/A | 50 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 6, 2019 | clinicaltrials |
| NCT04148885 | A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer | unknown | Phase 1 / Phase 2 | 44 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Nov 4, 2019 | clinicaltrials |
| NCT03572946 | Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection | unknown | N/A | 400 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Oct 14, 2019 | clinicaltrials |
| NCT04124107 | Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection | unknown | N/A | 50 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | Oct 14, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Jul 23, 2020source: clinicaltrials